SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
HHS-NIH-NIAID-BAA2025-1 | 2026 NIAID DMID Omnibus Broad Agency Announcement | |
Synopsis | ||
AMENDMENT FIVE The purpose of Amendment Five is to:
______________________________________________________________________ AMENDMENT FOUR The purpose of Amendment Four is to:
|
||
Office Location | Agency Name | Solicitation Base Posting Type |
NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
HHS-NIH-NIAID-BAA2025-1 | 2026 NIAID DMID Omnibus Broad Agency Announcement | |
Synopsis | ||
AMENDMENT FOUR The purpose of Amendment Four is to:
______________________________________________________________________ AMENDMENT THREE The purpose of Amendment Three is to:
|
||
Office Location | Agency Name | Solicitation Base Posting Type |
NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
HHS-NIH-NIAID-BAA2025-1 | 2026 NIAID DMID Omnibus Broad Agency Announcement | |
Synopsis | ||
AMENDMENT THREE The purpose of Amendment Three is to:
_______________________________________________________________________________ AMENDMENT TWO The purpose of Amendment Two is to:
|
||
Office Location | Agency Name | Solicitation Base Posting Type |
NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
HHS-NIH-NIAID-BAA2025-1 | 2026 NIAID DMID Omnibus Broad Agency Announcement | |
Synopsis | ||
AMENDMENT TWO The purpose of Amendment Two is to:
__________________________________________________________________________ AMENDMENT ONE The purpose of Amendment One is to:
|
||
Office Location | Agency Name | Solicitation Base Posting Type |
NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
HHS-NIH-NIAID-BAA2025-1 | 2026 NIAID DMID Omnibus Broad Agency Announcement | |
Synopsis | ||
AMENDMENT ONE The purpose of Amendment One is to:
_________________________________________________________________________ Introduction: The National Institute of Allergy and Infectious Diseases (NIAID), one of 27 institutes of the National Institutes of Health (NIH), an agency within the Department of Health and Human .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
HHS-NIH-NIAID-BAA2025-1 | 2026 NIAID DMID Omnibus Broad Agency Announcement | |
Synopsis | ||
Introduction: The National Institute of Allergy and Infectious Diseases (NIAID), one of 27 institutes of the National Institutes of Health (NIH), an agency within the Department of Health and Human Services (DHHS); conducts and supports research to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten millions of human lives. Through a variety of research grants and contracts, NIAID’s Division of Microbiology and Infectious Diseases (DMID) specifically supports extramural research to develop new medical countermeasures (MCMs) against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases. This Broad Agency Announcement (BAA) .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
NATIONAL INSTITUTES OF HEALTH | Combined Synopsis/Solicitation |
SetAside Type | ||
Solicitation ID | Solicitation Title | Solicitation Office |
HHS-NIH-NIAID-BAA2025-1 | 2026 NIAID DMID Omnibus Broad Agency Announcement | |
Synopsis | ||
Introduction: The National Institute of Allergy and Infectious Diseases (NIAID), one of 27 institutes of the National Institutes of Health, an agency within the Department of Health and Human Services (DHHS), conducts and supports research to understand, treat, and ultimately prevent the myriad infectious, immunologic, and allergic diseases that threaten millions of human lives. Through a variety of research grants and contracts, NIAID’s Division of Microbiology and Infectious Diseases (DMID) specifically supports extramural research to develop new medical countermeasures (MCMs) against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases. This Broad Agency Announcement (BAA) is .... Read More |
||
Office Location | Agency Name | Solicitation Base Posting Type |
NATIONAL INSTITUTES OF HEALTH | Presolicitation |